Sodium Zirconium Cyclosilicate

Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy Subjects

Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure

OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure

The ORTIZ Study: Optimising RASi Therapy With SZC

OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure (OPRA-HF)

Safety & Efficacy of Zirconium Silicate Dosed for 28 Days in Hyperkalemia.

Open-label Safety & Efficacy of ZS (Sodium Zirconium Cyclosilicate)10g qd to Extend Study ZS-004 in Hyperkalemia.

Open-label Safety and Efficacy of Sodium Zirconium Cyclosilicate for up to 12 Months

Reduce Incidence of Pre-Dialysis Hyperkalaemia With Sodium Zirconium Cyclosilicate in Chinese Subjects

Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease

Sodium Zirconium Cyclosilicate Lowers Hyperkalemia After Parathyroidectomy

Keeping RAASi Treatment With Optimal Potassium Control

A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients

Comparison of Potassium Binders in the ER

Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone

Sodium Zirconium Cyclosilicate to Allow Liberal Fruit and Vegetable Intake for Patients With CKD Stage 3b and 4